Skip to content

BONESUPPORT HOLDING AB (publ) – Invitation to conference call and webcast for Interim Report Q1 2022

Published: 2022-04-27

BONESUPPORT Holding AB (publ), a leading company in orthobiologics for the management of bone injuries, will publish its Interim Report Q1 2022, on the 4 May 2022 at 08.00 am CEST.

The Company will hold a conference call and an online presentation on the same day at 10.00 am CEST. The call will be hosted by Emil Billbäck, CEO and Håkan Johansson, CFO who will present the results and answer questions. The presentation will be held in English.

The dial-in numbers for the conference call are:

SE: +46 8 50558373
UK: +44 3333009273
US: +1 8338230586

The presentation will be webcasted and can be accessed from the following weblink:

For more information contact:

Emil Billbäck, CEO
+46 (0) 46 286 53 70

Håkan Johansson, CFO
+46 (0) 46 286 53 70

Cord Communications
Charlotte Stjerngren
+46 (0) 708 76 87 87


BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver. The company is based in Lund, Sweden, and the net sales amounted to SEK 213 million in 2021. Please visit for more information.
BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.